Arbajian E - Search Results

1

Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.

Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG, Mertens F. Arbajian E, et al. Am J Surg Pathol. 2014 Jun;38(6):801-8. doi: 10.1097/PAS.0000000000000158. Am J Surg Pathol. 2014. PMID: 24441665

2

A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone.

Arbajian E, Magnusson L, Brosjö O, Wejde J, Folpe AL, Nord KH, Mertens F. Arbajian E, et al. Am J Surg Pathol. 2013 Apr;37(4):613-6. doi: 10.1097/PAS.0b013e31827ae13b. Am J Surg Pathol. 2013. PMID: 23480895

3

Myoepithelioma of bone with a novel FUS-POU5F1 fusion gene.

Puls F, Arbajian E, Magnusson L, Douis H, Kindblom LG, Mertens F. Puls F, et al. Among authors: arbajian e. Histopathology. 2014 Dec;65(6):917-22. doi: 10.1111/his.12517. Epub 2014 Oct 31. Histopathology. 2014. PMID: 25066216

4

In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.

Arbajian E, Puls F, Antonescu CR, Amary F, Sciot R, Debiec-Rychter M, Sumathi VP, Järås M, Magnusson L, Nilsson J, Hofvander J, Mertens F. Arbajian E, et al. Clin Cancer Res. 2017 Dec 1;23(23):7426-7434. doi: 10.1158/1078-0432.CCR-17-1856. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939748

5

Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.

Puls F, Agaimy A, Flucke U, Mentzel T, Sumathi VP, Ploegmakers M, Stoehr R, Kindblom LG, Hansson M, Sydow S, Arbajian E, Mertens F. Puls F, et al. Among authors: arbajian e. Am J Surg Pathol. 2020 May;44(5):594-606. doi: 10.1097/PAS.0000000000001423. Am J Surg Pathol. 2020. PMID: 31913156

6

Frequent low-level mutations of protein kinase D2 in angiolipoma.

Hofvander J, Arbajian E, Stenkula KG, Lindkvist-Petersson K, Larsson M, Nilsson J, Magnusson L, von Steyern FV, Rissler P, Hornick JL, Mertens F. Hofvander J, et al. Among authors: arbajian e. J Pathol. 2017 Apr;241(5):578-582. doi: 10.1002/path.4865. Epub 2017 Feb 27. J Pathol. 2017. PMID: 28139834

7

Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.

Arbajian E, Köster J, Vult von Steyern F, Mertens F. Arbajian E, et al. Mod Pathol. 2018 Jan;31(1):93-100. doi: 10.1038/modpathol.2017.113. Epub 2017 Sep 8. Mod Pathol. 2018. PMID: 28884746 Free article.

8

Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.

Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F. Al-Ibraheemi A, et al. Among authors: arbajian e. Mod Pathol. 2019 Mar;32(3):423-434. doi: 10.1038/s41379-018-0150-3. Epub 2018 Oct 11. Mod Pathol. 2019. PMID: 30310176 Free article.

9

Deep sequencing of myxoinflammatory fibroblastic sarcoma.

Arbajian E, Hofvander J, Magnusson L, Mertens F. Arbajian E, et al. Genes Chromosomes Cancer. 2020 May;59(5):309-317. doi: 10.1002/gcc.22832. Epub 2020 Jan 31. Genes Chromosomes Cancer. 2020. PMID: 31898851

10

Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.

Nord KH, Nilsson J, Arbajian E, Vult von Steyern F, Brosjö O, Cleton-Jansen AM, Szuhai K, Hogendoorn PC. Nord KH, et al. Among authors: arbajian e. PLoS One. 2013 Nov 13;8(11):e80725. doi: 10.1371/journal.pone.0080725. eCollection 2013. PLoS One. 2013. PMID: 24236197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page